Why is Vivo Bio Tech falling/rising?

As of 15-Jul, Vivo Bio Tech Ltd. is currently priced at 35.99, experiencing a slight decline of 0.01, which represents a decrease of 0.03%. The stock has underperformed its sector today by 1.28% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -1.04%, while it has underperformed significantly over the past month and year, with returns of -5.51% and -5.04%, respectively. Despite a notable increase in delivery volume by 37.67% against the 5-day average, the overall sentiment remains negative, compounded by a decrease in promoter holding to 39.06%. While the company has shown a substantial profit increase of 187.8% over the past year, its weak long-term fundamentals, including a -3.36% CAGR growth in net sales and a low return on equity, continue to weigh heavily on investor confidence.
In the broader market context, Vivo Bio Tech's performance has been less favorable compared to the Sensex, which has gained 1.79% over the past month and 5.67% year-to-date. The stock's negative trajectory is further highlighted by its underperformance against the BSE500 over various time frames, including the last three years and one year. This broader context of market performance, coupled with the company's weak financial indicators and declining promoter confidence, suggests that investors are cautious, leading to the stock's current downward movement.